Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Federated Genomics Analysis Market Report 2026 | Capitalize on 21.2% CAGR to $4.27B by 2030 as AWS, Google, Microsoft, and NVIDIA scale privacy-preserving AI

globenewswire.com
MSFT Microsoft is mentioned as a key player scaling privacy-preserving AI in the federated genomics analysis market, indicating a positive outlook for its involvement in this growing sector. GOOGL Alphabet (Google) is identified as a company scaling privacy-preserving AI within the federated genomics analysis market, suggesting a positive impact from this expanding industry. AMZN Amazon (AWS) is highlighted for scaling privacy-preserving AI in the federated genomics analysis market, indicating a positive growth opportunity for its cloud services in this domain. NVDA NVIDIA is recognized for scaling privacy-preserving AI in the federated genomics analysis market, positioning it favorably due to its strong presence in AI and high-performance computing.

Global Federated Genomics Analysis Market Report 2026 | Capitalize on 21.2% CAGR to $4.27B by 2030 as AWS, Google, Microsoft, and NVIDIA scale privacy-preserving AI Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Federated Genomics Analysis Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global federated genomics analysis market is experiencing exponential growth as healthcare organizations, research institutions, and biotechnology companies seek secure methods for analyzing distributed genomic data. The market is projected to increase from $1.64 billion in 2025 to $1.98 billion in 2026, representing a compound annual growth rate (CAGR) of 21%. Historic growth has been supported by the rising volume of genomic sequencing data, stricter data privacy regulations, expansion of multicenter clinical trials, increased investment in precision medicine research, and advances in high-performance computing infrastructure.

Strong momentum is expected to continue throughout the forecast period. The federated genomics analysis market is forecast to reach $4.27 billion by 2030, expanding at a CAGR of 21.2%. Growth will be driven by the increasing adoption of federated learning in healthcare, demand for cross-border genomic collaboration, rising cybersecurity requirements for health data, expansion of cloud-based genomics platforms, and integration of artificial intelligence into genomic interpretation.

Key federated genomics analysis market trends include the growing use of privacy-preserving genomic analytics, broader cross-institutional research collaboration, and expansion of distributed data management platforms. Demand is also increasing for secure multisite genomic studies and federated models that support clinical genomics without requiring participating organizations to transfer raw patient data.

The expanding adoption of precision medicine remains a major market driver. Modern precision medicine programs increasingly depend on large and diverse genomic datasets collected across hospitals, laboratories, academic institutions, and research networks. Federated genomics analysis enables these organizations to examine distributed datasets while maintaining data security and meeting regulatory and ethical obligations. This approach supports broader investigation of genetic variation and helps researchers develop more targeted therapies and diagnostic strategies.

Evidence of precision medicine growth can be seen in the increasing number of personalized treatments receiving regulatory approval. According to the Personalized Medicine Coalition, the U.S. Food and Drug Administration approved 16 new personalized therapies for patients with rare diseases in 2023, compared with six in 2022. This expansion is strengthening demand for scalable genomic analysis platforms capable of supporting secure research across multiple data environments.

Technology providers are responding by developing federated analytics platforms that execute queries and analyses locally before aggregating approved insights. In September 2023, Canada-based genomics software company DNAstack launched Omics AI, a federated analytics platform designed to support secure querying and collaborative analysis across global genomic data silos without moving the underlying data. The platform supports Global Alliance for Genomics and Health interoperability standards, as well as compliance requirements associated with HIPAA and GDPR. Its capabilities include data management, federated search, and collaborative workflows for research areas such as infectious diseases and neuroscience.

Strategic partnerships are also contributing to federated genomics analysis market development. In December 2025, U.S.-based data analytics company Datma partnered with Australia-based biotechnology company Rhythm Biosciences to use federated real-world data in the advancement of genomic diagnostics. The collaboration is intended to accelerate the development of precise, data-driven genomic tests, improve diagnostic accuracy, and generate privacy-preserving insights from distributed healthcare datasets.

North America was the largest region in the federated genomics analysis market in 2025, supported by advanced healthcare research infrastructure, strong precision medicine investment, and widespread adoption of genomic technologies. Asia-Pacific is expected to be the fastest-growing region during the forecast period. Geographic coverage includes Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.

Markets Covered:

1) By Component: Software; Hardware; Services

2) By Deployment Mode: On-Premises; Cloud

3) By Application: Clinical Research; Drug Discovery; Precision Medicine; Diagnostics; Other Applications

4) By End-User: Hospitals and Clinics; Research Institutes; Pharmaceutical and Biotechnology Companies; Other End Users

Subsegments:

1) By Software: Federated Learning Platforms; Genomic Data Integration Software; Privacy Preserving Analytics Software; Distributed Data Management Software; Visualization and Reporting Software

2) By Hardware: High Performance Computing Systems; Data Storage Servers; Secure Networking Infrastructure; Edge Computing Devices; Encryption and Security Appliances

3) By Services: Implementation and Integration Services; Data Security and Compliance Services; Managed Analytics Services; Consulting and Advisory Services; Maintenance and Technical Support Services

Time Series:

Five years historic and ten years forecast.

Data:

Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation:

Country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

Companies Featured

The companies featured in this Federated Genomics Analysis market report include:

For more information about this report visit https://www.researchandmarkets.com/r/aflnms

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.